IRIS UniCatt

Pinto, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 19.268
NA - Nord America 5.187
AS - Asia 3.326
SA - Sud America 679
AF - Africa 129
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 15
AN - Antartide 1
Totale 28.620
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 13.514
US - Stati Uniti d'America 5.030
DE - Germania 1.891
SG - Singapore 1.532
CN - Cina 854
SE - Svezia 787
NL - Olanda 768
BR - Brasile 549
FR - Francia 493
UA - Ucraina 464
GB - Regno Unito 314
PL - Polonia 290
IN - India 217
IE - Irlanda 182
VN - Vietnam 143
ID - Indonesia 126
RU - Federazione Russa 112
FI - Finlandia 108
CA - Canada 95
CH - Svizzera 88
JP - Giappone 67
HK - Hong Kong 65
TR - Turchia 64
BE - Belgio 61
AR - Argentina 48
BD - Bangladesh 45
ES - Italia 45
MX - Messico 35
ZA - Sudafrica 31
IQ - Iraq 27
EC - Ecuador 24
CI - Costa d'Avorio 23
MA - Marocco 23
IR - Iran 22
AT - Austria 19
PK - Pakistan 19
RO - Romania 16
AL - Albania 15
KR - Corea 15
LT - Lituania 15
VE - Venezuela 15
CO - Colombia 14
JO - Giordania 14
AE - Emirati Arabi Uniti 13
CZ - Repubblica Ceca 13
AU - Australia 12
AZ - Azerbaigian 12
SA - Arabia Saudita 12
EU - Europa 11
EG - Egitto 10
HU - Ungheria 10
UZ - Uzbekistan 10
CL - Cile 9
GR - Grecia 9
MY - Malesia 9
TW - Taiwan 9
BZ - Belize 8
PE - Perù 8
KE - Kenya 7
PH - Filippine 7
TH - Thailandia 7
TN - Tunisia 7
BG - Bulgaria 6
PY - Paraguay 6
PT - Portogallo 5
SM - San Marino 5
SN - Senegal 5
DK - Danimarca 4
ET - Etiopia 4
LB - Libano 4
LK - Sri Lanka 4
NP - Nepal 4
RS - Serbia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BH - Bahrain 3
BO - Bolivia 3
BY - Bielorussia 3
CR - Costa Rica 3
CV - Capo Verde 3
DZ - Algeria 3
HR - Croazia 3
IL - Israele 3
IS - Islanda 3
JM - Giamaica 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LU - Lussemburgo 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
OM - Oman 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
CM - Camerun 2
DO - Repubblica Dominicana 2
EE - Estonia 2
KH - Cambogia 2
KW - Kuwait 2
Totale 28.588
Salva come PNG Salva come JPEG
Città #
Milan 1.349
Rome 1.167
Chandler 914
Singapore 678
Ashburn 453
Naples 384
Florence 252
Jacksonville 245
Turin 245
Bologna 202
Warsaw 201
San Mateo 191
Beijing 188
Ann Arbor 176
Dublin 175
Palermo 170
Los Angeles 166
Bari 159
Wilmington 143
Nanjing 125
Catania 123
Genoa 117
Jakarta 111
Verona 109
Houston 108
Nürnberg 107
Dearborn 103
Woodbridge 94
Munich 89
New York 88
Boston 77
Fairfield 77
Nanchang 75
Bremen 70
Brescia 64
São Paulo 64
Lawrence 62
Hong Kong 61
Chicago 60
Kraków 60
Padova 60
Frankfurt am Main 58
Seattle 54
Redwood City 53
Venice 53
Moscow 52
Cagliari 51
Cattolica 50
Hefei 50
Ho Chi Minh City 50
Parma 48
Brussels 46
Taranto 46
The Dalles 46
Dallas 43
Pescara 42
Princeton 42
Bergamo 41
Ottawa 41
Perugia 40
Messina 39
Reggio Emilia 39
Marseille 37
Salerno 36
Livorno 35
Lancaster 34
Hanoi 32
Mountain View 32
Izmir 30
Redmond 30
Falls Church 29
Modena 29
Paris 29
Kadoma 28
Lucca 28
Trieste 28
Kunming 27
San Jose 27
Monza 26
Novara 26
Augusta 25
Cambridge 25
Helsinki 25
Buffalo 24
Tianjin 24
Abidjan 23
Amsterdam 23
Brooklyn 23
Santa Clara 23
Tokyo 23
London 22
Rimini 22
Hyderabad 21
Johannesburg 20
Montreal 20
University Park 20
Belo Horizonte 19
Caserta 19
Hangzhou 19
Hebei 19
Totale 11.328
Salva come PNG Salva come JPEG
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 11.228
Iniezione transuretrale intracervicale di tossina botulinica tipo A nel trattamento della dissinergia del collo vescicale refrattaria a terapia medica 1.184
Iniezione intracervicale di OnabotulinotossinaA per il trattamento dell'ostruzione primitiva del collo vescicale refrattaria alla terapia medica. Una nuova opzione terapeutica 905
Ruolo della risonanza magnetica funzionale (DCE-MRI, DWI-MRI)in pazienti sottoposti a saturation biopsy per persistente sospetto di carcinoma prostatico nonostante un primo set bioptico negativo: risultati preliminari su esperienza monocentrica 854
Il ruolo della chemioimmunoterapia endovescicale nella neoplasia della vescica non muscolo invasiva “ non responder” 562
La tecnologia robotica nel contesto urologico italiano: analisi economica costo-efficacia 399
MALAT1 and HOTAIR long non-coding RNAs play opposite role in estrogen-mediated transcriptional regulation in prostate cancer cells 395
High intensity focused ultrasound (HIFU) in prostate cancer: today’s outcomes and tomorrow’s perspectives 333
Efficacia di un programma supervisionato perioperatorio di fisioterapia del pavimento pelvico per il miglioramento del recupero della continenza dopo prostatectomia radicale: trial randomizzato controllato 312
Studio trasversale sui sintomi e sulle complicanze del basso apparato urinario e sul loro impatto sulla qualità  della vita connessa alla salute (HRQL) in una coorte di pazienti con sclerosi multipla (MS) utilizzando questionari standardizzati 304
High-intensity focused ultrasound in prostate cancer: Today's outcomes and tomorrow's perspectives 298
Pros-IT CNR: an Italian prostate cancer monitoring project 264
H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer. 246
Efficacy of a supervised low-intensity regimen of perioperative pelvic floor muscle training in reducing postprostatectomy urinary incontinence: A randomized controlled trial 233
E-CADHERIN AND IL-6 SERUM LEVELS IN PATIENTS AFFECTED BY PROSTATE CANCER BEFORE AND AFTER PROSTATECTOMY 230
Le infezioni delle vie urinarie 223
Do testis germinal tumours express PTTG (Pituitary Transforminf Tumour Gene) 206
SEXUAL DYSFUNCTIONS IN PATIENTS AFFECTED BY MULTIPLE SCLEROSIS: EVALUATION IN A CONTEMPORARY COHORT FROM A REFERRAL CENTER 201
URINARY PROTEOMICS IN RENAL CELL CANCER BY MALDI-TOF MASS SPECTROMETRY:A PRELIMINARY CONTROLLED STUDY 200
Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma 183
Soluble E-cadherin and IL-6 serum levels in patients affected by prostate cancer before and after prostatectomy 176
Metabolic reprogramming by malat1 depletion in prostate cancer 172
OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes 171
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results 171
The occult urothelial cancer 171
Robot technology in the Italian Health-CARE system: cost-efficacy economic analysis 169
Complications of Extracorporeal Shock Wave Lithotripsy for Urinary Stones: To Know and to Manage Them–A Review 168
Male infertility: non-surgical therapy 165
Hot topics in urological health economics. A mini review 156
Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex 156
Human factors in surgery: from Three Mile Island to the operating room 155
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study 152
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia treated with intraprostatica onabotulinumtoxinA: 3 month results of a prospective single-armed cohort study 149
Paraneoplastic Dermatomyositis Associated With Panurothelial Transitional Cell Carcinoma: A Case Report and Literature Review 149
Imaging in prostate cancer diagnosis: present role and future perspectives 148
[Overactive bladder syndrome: the social and economic perspective] 148
IMAGING IN BLADDER CANCER: PRESENT ROLE AND FUTURE PERPECTIVES.Totaro A, Pinto F, Brescia A, Racioppi M, Cappa E, D'Agostino D, Volpe A, Sacco E, Palermo G, Valentini AL, Bassi PF. 148
Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial 147
Bladder and prostate metastasis from small cell lung cancer: a rare entity 146
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 146
Brachytherapy in men with prostate cancer: update on indications and outcomes 145
(99m)Tc-Mag3 Diuretic Renography In Assessment Of Obstructive Uropathy. The New Test F+10sp: A Step Ahead In The Differential Diagnosis 143
L' era del PCA3: risultati preliminari di uno studio pragmatico monocentrico 142
Advanced bladder cancer: New agents and new approaches. A review 141
Imaging of renal cell carcinoma: state of the art and recent advances 141
Imaging in prostate cancer staging: present role e future perspectives 141
Children with special health care needs attending emergency department in Italy: analysis of 3479 cases 141
Hifu as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 138
Advanced bladder cancer: New agents and new approaches. A review 136
Size of Bladder Cancers: Correlation among Different Types of Measurement 136
Treatment of bladder neck dissynergia with transurethral injection of OnabotulinumtoxinA: objective and patient-reported results 134
Therapeutic strategies in penile cancer: state of the art 134
Clinical, pathological and molecular prognostic factors in prostate cancer decision-making process 133
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 129
Imaging in prostate cancer staging: present role and future perspectives 127
Inhibition of prostate efferent neurotransmission by amikacin 126
Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy? 125
H19-Dependent Transcriptional Regulation of beta 3 and beta 4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer 124
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 123
Bladder pain syndrome associated with highest impact on sexual function among women with lower urinary tract symptoms 122
Imaging in Prostate Cancer Diagnosis: Present Role and Future Perspectives. 122
Circulating tumor cells as prognostic biological marker in different stages prostate cancer and the effect of different therapeutic approaches on their expression 122
Circumcision: history, religion and law 121
Local relapse of prostate cancer after primary definitive treatment: the management 121
High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 120
The occult urothelial cancer 118
Value of Current Chemotherapy and Surgery in Advanced and Metastatic Bladder Cancer 117
Imaging of renal cell carcinoma: state of the art and recent advances 114
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging-Hystopatology correlations 114
Imaging in prostate cancer diagnosis: present role and future perspectives 108
Titanised Transobturator Sling Placement for Male Stress Urinary Incontinence Using an Inside-Out Single-Incision Technique: Minimum 12-Months Follow-Up Study 108
Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy 108
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study) 102
Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer 100
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging–Hystopatology correlations 98
Intensive intravesical mitomycin C therapy in non-muscle-invasive bladder cancer: a dose intensity approach. 95
Imaging of renal cell carcinoma: state of the art and recent advances. 95
Prognostic Impact of H19/Cell Adhesion Molecules Circuitry on Prostate Cancer Biopsy 90
Anti-anginal drugs: Systematic review and clinical implications 90
A circulating miRNA assay as a first-line test for prostate cancer screening 90
A circulating miRNA assay as a first-line test for prostate cancer screening 89
[Doping and urologic tumors] 87
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging—Hystopatology correlations 86
Intraprostatic botulinum toxin type "A" injection in patients with benign prostatic hyperplasia and unsatisfactory response to medical therapy: A randomized, double-blind, controlled trial using urodynamic evaluation 86
Anti-Anginal drugs-beliefs and evidence: Systematic review covering 50 years of medical treatment 85
Sports and Genitourinary Traumas 85
Immediate ileal ureter replacement for ureteral avulsion during ureterescopy 79
[Continuing evolution of statistical tests in medical research] 77
The cost of treatment and follow-up of bladder cancer in Italy 77
Comparison of PIV and Other Immune Inflammation Markers of Oncological and Survival Outcomes in Patients Undergoing Radical Cystectomy 74
[Androgen-deprivation therapy in prostate cancer: clinical evidence and future perspectives] 74
Shock-wave lithotripsy or ureterorenoscopy for renal stones? 73
[Prostatitis syndromes and sporting activities] 72
[Sport, infertility and erectile dysfunction] 70
Predictive Factors for Major Complications and Urological Cancer Diagnosis in Older Adults (≥80 Years) Admitted to the Emergency Department for Hematuria 69
Clinical Significance of Perinephric Fluid Collection in Patients with Renal Colic and Urolithiasis: A Retrospective Analysis 59
Circumcision: history, religion and law 59
Bladder tumor markers: A review of the literature 59
Rate of clinically significant prostate cancer on repeat saturation biopsy after a diagnosis of atypical small acinar proliferation 58
Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and Perspectives 56
Totale 28.231
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.278
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.278
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021763 0 0 0 0 0 80 140 58 143 83 187 72
2021/20221.427 126 90 62 119 111 77 66 181 102 102 177 214
2022/20233.938 364 344 266 461 187 407 173 316 428 255 417 320
2023/20245.910 321 534 389 462 453 452 481 587 430 582 561 658
2024/20257.927 596 683 721 649 777 592 632 638 841 577 666 555
2025/20263.847 1.029 354 471 657 1.054 282 0 0 0 0 0 0
Totale 28.807